pre-miRNA Information | |
---|---|
pre-miRNA | hsa-mir-1247 |
Genomic Coordinates | chr14: 101560287 - 101560422 |
Synonyms | MIRN1247, hsa-mir-1247, MIR1247 |
Description | Homo sapiens miR-1247 stem-loop |
Comment | None |
RNA Secondary Structure | |
Associated Diseases |
Mature miRNA Information | |||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mature miRNA | hsa-miR-1247-3p | ||||||||||||||||||||||||||||||
Sequence | 74| CCCCGGGAACGUCGAGACUGGAGC |97 | ||||||||||||||||||||||||||||||
Evidence | Not_experimental | ||||||||||||||||||||||||||||||
Experiments | |||||||||||||||||||||||||||||||
SNPs in miRNA |
|
||||||||||||||||||||||||||||||
Putative Targets |
miRNA Expression profile | |
---|---|
Human miRNA Tissue Atlas | |
miRNAs in Extracellular Vesicles |
|
Circulating MicroRNA Expression Profiling |
Gene Information | |||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Gene Symbol | XPNPEP3 | ||||||||||||||||||||
Synonyms | APP3, ICP55, NPHPL1 | ||||||||||||||||||||
Description | X-prolyl aminopeptidase 3 | ||||||||||||||||||||
Transcript | NM_022098 | ||||||||||||||||||||
Expression | |||||||||||||||||||||
Putative miRNA Targets on XPNPEP3 | |||||||||||||||||||||
3'UTR of XPNPEP3 (miRNA target sites are highlighted) |
>XPNPEP3|NM_022098|3'UTR 1 CCTTCACTGCGGCCCACATGCACCTCAGGTTCAAAATGGGTGTCTTCTGGCAGCCCTGCACGTGTGCTTTCTGAGTGTCT 81 CTGTGTGTGCATTAATATATGCATTCCATTTGGGAGCATAGCAGCTGTGTGAATGTATGTAATTGTGTGTGGGGGGTTTT 161 TTGTTTTAAGTAGTTAGAAGTCTGGGAAAATGAATTTTTGAATAGTATGTTACTGCAGCTTTGGTAACATTAATTCTATA 241 GAATTAATGATCAGAGCAAGTTTAATTTTTAAACATAAAGGTCTTGGTTACACATGTCCATGCATTCCAGTTAACACATT 321 TAAACATATAGAAAATTCACTTCTTCTTTCAAGTCCTTCCCTTTCTATACTTTTGCTGAGATCAACCCAATATCATAAGA 401 AGTTTGTGTGATGCCTGTATTTTTAGCTAATTACCAAGGTCTCTGCCTATGCAAAAATTCATCTTTCGGTGATTGTGGGC 481 GGCCAATACATACCTTCTGTAACTCCTCCCTACCTATTCTAGATCCTGCATATCTACTGGAGCCATATGAGCCCTCAGGG 561 GCACTGGTGTCCTGCAGTCTTACTAGTCAGCCACAGTCCAGGTTCCAGCAACACTAGCTACCTACCAAACAAAACACTTC 641 TGAGCTTTTCTTGCCATTTGGTTGCCTGGGACCTGGAAAGTGTTTAGATTCTTGATAAAGATGGAAATGGAAGAGAAAGA 721 AAATTATATATGTATATACTAAAGATCCAGACATCAGGGCTGGGCACAGCGGTTCCGCCTGTAATCCCAGCACTTTGGGA 801 GGTCCAGGCAGGTGGATCTCTTGAGACCAGGAGGTCAAGACCAGCCTGGCCAACGTGGTGAAACACTGTCTCTACTAAAA 881 ATACAAAAATGAGCTGGGTGTGATGATACATGCCTGTAATCCTGGCTACTTGGGAGGCTGAGGCATGAGAATTGCTTGAA 961 CCTGGGAGGTGGAGGTTGCAGTGAGCTGAGCTCATGCGACTGCACTCCAGCCTGGGTGACTGAGCAAGACTCTGCCTCAA 1041 AAAAACAAATAAATAAATAAAATCCTGACATCCTGCCATCTTTTCTCTTCAATTTAAAGTTGATTTCTTAATGATGACTT 1121 CAAAAATTAATAAAAAGAAAAGAAAAAAATGATTTCTGGCCGGGCGTGGTGGCTCAAGCCTGTAATCCCAGCACTTTGGG 1201 AGGCCGAGGTGGGCGGATCACGAGGTCAGGAGATTGAGACCTCCTGGCTAACACGGTGAAACCCCGTCTTTACTAAAAAT 1281 ACAAAAAAAATTAGCTGGGCGTGGTGGCGGATGCCTGTAGTCCCAGCTACTCAGGAGGCTGAGGCAGGAGAATGGCGTGA 1361 ACCCAGAAGGCAGAGCTTGCAGTGAGCCAAGATCGCGCCACTGCACTCCAGCCTGGGTGACAGAGCGAGACTCCGTCTCA 1441 AAAAAAAAAAAAAAAAAGAAAAAAAAAAGAAAGATTTCTTTCGCAGATATCCCTGCTCCCTCTATAGATTCTTAATGCAC 1521 TGACCCTCACAGGTTACCCTTTTAGCTGTTGTGCTGCGCAGGAGCAGATCCTCTACTTACGTACCCTGTCAGAGTCACAG 1601 TAGTAGCGCCCAGTTTTCAGAGAAGTACCCCTGTTATCATTCTGTGATTTCCTCTAGTGCTAATAGAAACAAAATATGGA 1681 ATCTACCAAGTACCCGTAAATATCCTATGATTCTTATCTTTCTTTGATACTAGCACTGGGAGTGCAGTGGTAAAGAGTCA 1761 TACTTCTTTTTTTTTTTTTTTTTTGGAGACAGAGTCTCGCTCTGTCGCCTGGGCTGGATGGAGTGCAGTGGCGTAATCTC 1841 AGCTCACTACAACCTCCACCACCTGGGTTCAGGCAATTCTCCTGCCTCAGCCTCCCAAGTAACTGGGACTACAGGTGCAC 1921 GCTGCCATGCCCAGCTAATTTTTTGTATTTTAGTAGAGACAGGGTTTCACCCTGTTGCCCAGGCCGGTCTCAAACTCCTG 2001 AGCTCCGGCAATCCGCCCACCTCAGCCTCCCAAAGTGCTAGGATTACAGGCATGAGCCACTGCGCCCGGTGTAAGAGTCA 2081 TATTTTTTTAAACACAAACATTGGATACAATTATACAGCAACTCAGTTTGCAAGATGAACAGGGCTAGATTACCACAGAT 2161 AGCTTATTTAGGAGCGTCTGTGATAGAGGGAAGCTTTAAGAACCAGTGTGTTCACCTCCTTTAAACCTGGATATGAGGTC 2241 AAGATGTATAAAACATGCCAATTGTTAGAACACAAATTTGAGGGTTTCTTAAAAAAACAATTTGTATTAGGGAAGCACAA 2321 GCTAGGGGATTAACAATCTCTGTAATGCTGGAAGTTTGCCTATCTTATCAGGGAAACCCAGGGTACAGAGTGAAAAGCAG 2401 ACAGGCAGTGACTTCCTCAAGAGACAGATAATGTGAAAACAAAAGTGATACAAATCATATCCTGACAGTGCTAGCCTAGG 2481 AATGCCTGGCTTTGCGCACCTTATCTAAGCAGCTCTCAGAATGGAGGCTGCACAGCTGGAGTCTCCATCCCCCATACCCA 2561 CCTTCCCACCTCCCTCCAATTTCTCAATCCAGAGCTTTTTAAAAAAAGGGGAGGGAAATAACTCCACAGCTCTGGCTGCT 2641 CACTTCCCAGGCTCTGTGCCCCCAACAGCCCTTTCCTTGGATTGTGTTTCCTTTGTTCATTTGTAATCCAGGAATAAGGA 2721 ATTTCCTTTTCTTCTTGTATCATTTTCTTTTCTTTTCTTTTTTTTTTTTTTTTTGAGACGGAGTCTCACACTGTCACCGG 2801 GGCTGGTGTGCAATAGCGAGACCTCAGCTCCCTGCAACCTCCATCTCCCAGGTTCAAGCGATTCTCCTGCCTCAGCCTCC 2881 CGAATAGCTAGGAATACAGGCGCCTGCCACCACACCCGGCTATTTTTTTGTATTTTAAATAGAGACGAGGTTTCACTGTG 2961 TTGGCCAGGCTGGTCTCGAACTCCTGACCTCATGATCTGCCCGCCTCGGCCTCCCTAAGTGCTGCGATTACAGACGTGAG 3041 CCACCGCACCTCCTGTATCATTTTCTATGGTCTAAACTTTTCTAGCTAAAAGCCTAGGTAGCTTGTATGTATAGCAGCAT 3121 ACTTGGACATGAAACACACTTCTGGTTAGATTCCAGTCAAGTTCTATAGGTGTTATTGGTAGGCAGAAAGGCTGTTGTAG 3201 AATTCTTCTGGTGATTTTCAGTCCCTGACCCAGGTATATTGTCCTTTGAGTCCCAGATTAACTAACTATAGCAGCTAAGC 3281 ATTTGAATCAGACTTCTCATAGCAATGTTATGGGCTGTCTGATATATTCAGGATTTGTTGAGCAGATAAGCTGTGTGTGA 3361 TCTTACTCATTCTCAGCCATGCCGCAGACATACCCATTTCCCTTTAGTAATTTTTTAATACAGAGAATGCTATTAACTGT 3441 TACTGGATATCAAATAATTTTATTTTTCTAATAGTATTTTCCAAATATTTCTTAAAATTCTTAAAATTTAGGTTAAAGTT 3521 TGCTGGTCTCTTACATTTAATAAAGCTGGGACTTGAAGACTTACCATAGTTTTCAACTGCCTTTGCAAGTTCATAAACTT 3601 CTAAGGGTAAAAAGTGAATAAGATAAATTCAGAGTTTTAAGGTAAAGGCTTTATATTAGCTTTTTTTTTTTTTAAAGGTT 3681 TTTTGTGGGGTTTTTTTGTTTTTTTTTTTTTTGAGATGGAGTCTCGCTCTGTCACCCAGGCTGGAGTGCAGTGGCACGAT 3761 CTTGGCTCACTGCAACCTCCATCTCCCGGGTTCAGGCAATTCTTCTGCCTCAGCCTCCTGAGTAGCTGGGACTACAGGCG 3841 CGTGCCACCATGCCCGGCTAGTTTATTGTATTTTTAGTAGAGATGGGGTTTTACTGTGTTAGCCAGGATGGTCTCAATCT 3921 CCTGACCTCATAATCTGCCCACCTCAGCCTCCCAAAGTGCTGGGATTACAGGCGTGAGCCACTGCACCCAGCCTTTTTAA 4001 AGTTTTTAATTGACATATAATTGTACGTATTTACAGGGTAAATAATGATGTTTTGATACATATATAATGATCAGATCAGA 4081 ACAATTAGCATATCCATCACATTGAACATTTATCATTTATTTGTGTTGAGCCTTTAGTTCTTTTTTTTTTTTGAGATAGA 4161 GTCTCACTCTGTCACCCAGGCTGGAGTACAGTGGTGTGATCTTGGCTCACTGCAACCTCCACCCACCGGCTTCAACCAAT 4241 TCTCCTGCCTCAGCCTCCCTAGTAACTGGGATTACAGGCACCTGCCACCACACCCAATTTTTGTATTTTTAGTAGAGACG 4321 GGGTTTCACCATCTTGGCCAGGCCAGGCTGGTCTTGATCTCCTGACCTTGTGATCCACCCACCTCAGCTTCCCAAACTGC 4401 TGGGATTACAGGCATGAGCCACGGCCCCCAGCCAGAGACAGTCTTGCTTTGTCGCCAGGCTGGAGTGTAGTGGCGCCATC 4481 TTGGCTCACTGCAACCTCCAACTCCCTGGTTCAAGCAGTTCTCCTGCCTCAGCCTCCCAAGTAGCTGGGATTACAGGCAC 4561 GCACCACCATGCCCAGCTAATTTTTGTATTTTTAGTAGAGACAGGGTTTCACCATGTTGGCCAGGATGGTCTTGATCTCC 4641 TGACCTCGTGATCTGCCCACTTTGGCCTCCCAAAGTGCTGGGATTACAGGTGTGAGCCACCGTGCCCAGCCGAGCCTTTA 4721 GTTCTAAGTATAATAAATAATATATATACCAGGCATTCCTATTAAAAATCTTAACTTAAAAAAAATTACTCAAATGTTAC 4801 TACTGGAATTTTTCTCCCTGAATTGAAGATACATGGTTAGATCATTAACAATACCACCTAAATGAAGGAAACATATCTGG 4881 ATATCCAGTGTCACATACTTTTATGTATTTATTTCAGGAATTACTATTTTGTCACCATAATTAGGAAACAGACTGTGTTC 4961 TTTATTTGAAACACAACAGTATAAATACTATAGTAAAGTTGGGTGCAGTGGATCACAGCTATAATCCCAGCACTTTGGGA 5041 GACCAAGGAGGGATGGTCACTTGAGCCCAGGAGTTTGAGACCAGCCTAGGCAACATAGAGAGACCTTGTCTCAACAAAAA 5121 AATTTAAAGTTAGCCAGGTGTGGTGGTTTGCACCTATAGTCCCAGCTACTCAGGAGGCTGAGGTGGGAGGATCGCTTGAG 5201 CTTAGGAGGTCAAGGCTGCAGTGAGCCATGATTGTGCCACTTCACCCTGGGCAACAGAGAAAGACCCTGTCTCAATAAAA 5281 AAGAAGAGAAAAACTGGAGTGAGAACTCTCCTCCTCTCATAATCATAGTATCCACGTTAGGAAAATGCTTCTGAGAGTAA 5361 CTTAAAGTACTGTGTGTGCATCTTCCTTCAAAACCTTGCTTTTTTCTCCGTTTTTGTAAGGTGAGAAAGGGAAAAACCTT 5441 CACCGTAGAAATACTGTCTTGAGATTAAGATACAAATAAAACATGTTAAACCTCCATCTAAAGACATTGCAACTTATTAA 5521 AACAGAAAAATGTACCTTTGTTATGTCTTTCCAAATATCCACACCCACACCCTGTTCAGCTTTGTTAATAATACAGAGAT 5601 CAGAAATGTGAAGCACAAATGCTGCTTCTCCCCCTCCTGTTCCCATGTCAGAGATGGAGAAGAAAGCACAGTGAGCTGTT 5681 CACCAGTCCAGCGGTGACCTCGGAGTCCTTTGTAACAGTGTTTCCAATAACTTCTGCCAATAAAACAGAATTTGAGTTAG 5761 AACCTATCTGCTGTCCCTCAACTAGTGTCTGATAGCTGAGAATGTAATTCGTTTGTGTGTCTATTAGAAAATTAGGCAGG 5841 CACCACAGACAGTAGCAACATAAAGGAACCTGCTTAGAAGAGGTTTTTATGGTGTGATTGTGTTTTTTTTTTTTTAATTT 5921 TTGTTTCCTGAAGTAGAATCCATAGCTCAAAACAAGTTTTAAGCCTGAGAAAATATAATTTGAGGTGTTTTTTATGCTCC 6001 TAATGAAAAGATGAATGAATGCATCATTAAACCTTAACAGTAGAGCAGAATTTCACTGTTACAAACCACATGGGTTCTCC 6081 TGGTTGTGCTGCTGTTCTCTACCTGTGTGTCACTGAGTTTGAGCATCATTATTGTTTGAATCAGAGGACCCACTGGAATC 6161 AAGGCTTCTTGGAATTGCGCAAGAATCTGAGAAAACTTCAATCTTTACCAGCATTTCTTAATGCTTTCCATGACTTTTGT 6241 GCAATTATATAAGTTCAGTTTAGACAAAATGCTGTTACTTTTTAAGGCATTACTAATAACTGAAAATAGTTACGTCATTG 6321 CCCATCAAGGGAAAAGCACTTGTAACTGTCATTTAAAAAAAATAAAACTATAAAACAATATAGAAAAAAAAAAAAAAAAA 6401 AA Target sites
Provided by authors
Predicted by miRanda
DRVs
SNPs
DRVs & SNPs
|
||||||||||||||||||||
miRNA-target interactions (Predicted by miRanda) |
|
||||||||||||||||||||
DRVs in gene 3'UTRs | |||||||||||||||||||||
SNPs in gene 3'UTRs |
Experimental Support 1 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | TZM-bl | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in GSM1462574. RNA binding protein: AGO2. Condition:TZM-bl ami BaL
... - Whisnant AW; Bogerd HP; Flores O; Ho P; et al., 2013, mBio. |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Whisnant AW; Bogerd HP; Flores O; Ho P; et al. - mBio, 2013
UNLABELLED: The question of how HIV-1 interfaces with cellular microRNA (miRNA) biogenesis and effector mechanisms has been highly controversial. Here, we first used deep sequencing of small RNAs present in two different infected cell lines (TZM-bl and C8166) and two types of primary human cells (CD4(+) peripheral blood mononuclear cells [PBMCs] and macrophages) to unequivocally demonstrate that HIV-1 does not encode any viral miRNAs. Perhaps surprisingly, we also observed that infection of T cells by HIV-1 has only a modest effect on the expression of cellular miRNAs at early times after infection. Comprehensive analysis of miRNA binding to the HIV-1 genome using the photoactivatable ribonucleoside-induced cross-linking and immunoprecipitation (PAR-CLIP) technique revealed several binding sites for cellular miRNAs, a subset of which were shown to be capable of mediating miRNA-mediated repression of gene expression. However, the main finding from this analysis is that HIV-1 transcripts are largely refractory to miRNA binding, most probably due to extensive viral RNA secondary structure. Together, these data demonstrate that HIV-1 neither encodes viral miRNAs nor strongly influences cellular miRNA expression, at least early after infection, and imply that HIV-1 transcripts have evolved to avoid inhibition by preexisting cellular miRNAs by adopting extensive RNA secondary structures that occlude most potential miRNA binding sites. IMPORTANCE: MicroRNAs (miRNAs) are a ubiquitous class of small regulatory RNAs that serve as posttranscriptional regulators of gene expression. Previous work has suggested that HIV-1 might subvert the function of the cellular miRNA machinery by expressing viral miRNAs or by dramatically altering the level of cellular miRNA expression. Using very sensitive approaches, we now demonstrate that neither of these ideas is in fact correct. Moreover, HIV-1 transcripts appear to largely avoid regulation by cellular miRNAs by adopting an extensive RNA secondary structure that occludes the ability of cellular miRNAs to interact with viral mRNAs. Together, these data suggest that HIV-1, rather than seeking to control miRNA function in infected cells, has instead evolved a mechanism to become largely invisible to cellular miRNA effector mechanisms.
LinkOut: [PMID: 23592263]
|
Experimental Support 2 for Functional miRNA-Target Interaction | |||||||
---|---|---|---|---|---|---|---|
miRNA:Target | ---- | ||||||
Validation Method |
|
||||||
Conditions | Prostate Tissue | ||||||
Location of target site | 3'UTR | ||||||
Tools used in this research | TargetScan , miRTarCLIP , Piranha | ||||||
Original Description (Extracted from the article) |
...
PAR-CLIP data was present in SRX1760638. RNA binding protein: AGO2. Condition:AGO-CLIP-PC3-miR148
... - Hamilton MP; Rajapakshe KI; Bader DA; Cerne et al., 2016, Neoplasia (New York, N.Y.). |
||||||
miRNA-target interactions (Provided by authors) |
|
||||||
Article |
- Hamilton MP; Rajapakshe KI; Bader DA; Cerne et al. - Neoplasia (New York, N.Y.), 2016
MicroRNA (miRNA) deregulation in prostate cancer (PCa) contributes to PCa initiation and metastatic progression. To comprehensively define the cancer-associated changes in miRNA targeting and function in commonly studied models of PCa, we performed photoactivatable ribonucleoside-enhanced cross-linking immunoprecipitation of the Argonaute protein in a panel of PCa cell lines modeling different stages of PCa progression. Using this comprehensive catalogue of miRNA targets, we analyzed miRNA targeting on known drivers of PCa and examined tissue-specific and stage-specific pathway targeting by miRNAs. We found that androgen receptor is the most frequently targeted PCa oncogene and that miR-148a targets the largest number of known PCa drivers. Globally, tissue-specific and stage-specific changes in miRNA targeting are driven by homeostatic response to active oncogenic pathways. Our findings indicate that, even in advanced PCa, the miRNA pool adapts to regulate continuing alterations in the cancer genome to balance oncogenic molecular changes. These findings are important because they are the first to globally characterize miRNA changes in PCa and demonstrate how the miRNA target spectrum responds to staged tumorigenesis.
LinkOut: [PMID: 27292025]
|
CLIP-seq Support 1 for dataset GSM1462574 | |
---|---|
Method / RBP | PAR-CLIP / AGO2 |
Cell line / Condition | TZM-bl / TZM-bl ami BaL |
Location of target site | ENST00000357137.4 | 3UTR | UCUCCCGGGUUCAGGCAAUUCUUCUG |
Tools used in this analysis | TargetScan, miRTarCLIP, and Piranha |
Article / Accession Series | PMID: 23592263 / GSE59944 |
CLIP-seq Viewer | Link |
MiRNA-Target Expression Profile | |||||||
---|---|---|---|---|---|---|---|
|
MiRNA-Target Expression Profile (TCGA) | |||||||
---|---|---|---|---|---|---|---|
|
228 hsa-miR-1247-3p Target Genes:
Functional analysis:
ID | Target | Description | Validation methods | |||||||||
Strong evidence | Less strong evidence | |||||||||||
MIRT107246 | PTGES2 | prostaglandin E synthase 2 | 2 | 2 | ||||||||
MIRT118004 | BLOC1S3 | biogenesis of lysosomal organelles complex 1 subunit 3 | 2 | 6 | ||||||||
MIRT345983 | BIRC5 | baculoviral IAP repeat containing 5 | 2 | 4 | ||||||||
MIRT369967 | ZNF264 | zinc finger protein 264 | 2 | 2 | ||||||||
MIRT451350 | ZNF573 | zinc finger protein 573 | 2 | 4 | ||||||||
MIRT451367 | UQCR11 | ubiquinol-cytochrome c reductase, complex III subunit XI | 2 | 2 | ||||||||
MIRT451450 | ZNF556 | zinc finger protein 556 | 2 | 4 | ||||||||
MIRT451766 | ZNF611 | zinc finger protein 611 | 2 | 6 | ||||||||
MIRT452065 | ZNF585B | zinc finger protein 585B | 2 | 8 | ||||||||
MIRT452346 | TG | thyroglobulin | 2 | 2 | ||||||||
MIRT452519 | TFDP2 | transcription factor Dp-2 | 2 | 6 | ||||||||
MIRT452631 | FAM162A | family with sequence similarity 162 member A | 2 | 2 | ||||||||
MIRT452896 | PSD4 | pleckstrin and Sec7 domain containing 4 | 2 | 4 | ||||||||
MIRT453263 | PARP11 | poly(ADP-ribose) polymerase family member 11 | 2 | 2 | ||||||||
MIRT453567 | RDH13 | retinol dehydrogenase 13 | 2 | 2 | ||||||||
MIRT453911 | GABRR2 | gamma-aminobutyric acid type A receptor rho2 subunit | 2 | 4 | ||||||||
MIRT454576 | NT5DC3 | 5'-nucleotidase domain containing 3 | 2 | 2 | ||||||||
MIRT454859 | ACOT9 | acyl-CoA thioesterase 9 | 2 | 4 | ||||||||
MIRT455094 | NMNAT1 | nicotinamide nucleotide adenylyltransferase 1 | 2 | 2 | ||||||||
MIRT455790 | TAF8 | TATA-box binding protein associated factor 8 | 2 | 2 | ||||||||
MIRT455932 | HECTD3 | HECT domain E3 ubiquitin protein ligase 3 | 2 | 2 | ||||||||
MIRT456213 | LIX1L | limb and CNS expressed 1 like | 2 | 4 | ||||||||
MIRT456238 | LHPP | phospholysine phosphohistidine inorganic pyrophosphate phosphatase | 2 | 6 | ||||||||
MIRT456279 | HRNR | hornerin | 2 | 2 | ||||||||
MIRT456665 | TIFA | TRAF interacting protein with forkhead associated domain | 2 | 2 | ||||||||
MIRT457088 | XPNPEP3 | X-prolyl aminopeptidase 3 | 2 | 2 | ||||||||
MIRT457322 | DUSP19 | dual specificity phosphatase 19 | 2 | 2 | ||||||||
MIRT457695 | ZNF587 | zinc finger protein 587 | 2 | 4 | ||||||||
MIRT458160 | LYRM4 | LYR motif containing 4 | 2 | 6 | ||||||||
MIRT458465 | SNX22 | sorting nexin 22 | 2 | 8 | ||||||||
MIRT458504 | MARVELD2 | MARVEL domain containing 2 | 2 | 2 | ||||||||
MIRT458514 | GSG2 | histone H3 associated protein kinase | 2 | 10 | ||||||||
MIRT458645 | SGPP2 | sphingosine-1-phosphate phosphatase 2 | 2 | 2 | ||||||||
MIRT458823 | ZNF843 | zinc finger protein 843 | 2 | 4 | ||||||||
MIRT459156 | NARF | nuclear prelamin A recognition factor | 2 | 2 | ||||||||
MIRT459182 | HSPA6 | heat shock protein family A (Hsp70) member 6 | 2 | 4 | ||||||||
MIRT459374 | MPLKIP | M-phase specific PLK1 interacting protein | 2 | 6 | ||||||||
MIRT459552 | BTD | biotinidase | 2 | 2 | ||||||||
MIRT459756 | SNRPD1 | small nuclear ribonucleoprotein D1 polypeptide | 2 | 2 | ||||||||
MIRT459860 | SVOP | SV2 related protein | 2 | 8 | ||||||||
MIRT460020 | DTX3L | deltex E3 ubiquitin ligase 3L | 2 | 6 | ||||||||
MIRT460233 | TNFRSF13C | TNF receptor superfamily member 13C | 2 | 2 | ||||||||
MIRT460275 | SLC26A2 | solute carrier family 26 member 2 | 2 | 2 | ||||||||
MIRT460461 | NOM1 | nucleolar protein with MIF4G domain 1 | 2 | 4 | ||||||||
MIRT460540 | TM4SF5 | transmembrane 4 L six family member 5 | 2 | 2 | ||||||||
MIRT460551 | IFNAR1 | interferon alpha and beta receptor subunit 1 | 2 | 6 | ||||||||
MIRT460978 | STK17B | serine/threonine kinase 17b | 2 | 2 | ||||||||
MIRT461421 | CTSL2 | cathepsin V | 1 | 2 | ||||||||
MIRT461960 | C3 | complement C3 | 2 | 4 | ||||||||
MIRT462529 | DHODH | dihydroorotate dehydrogenase (quinone) | 2 | 6 | ||||||||
MIRT462864 | CYP51A1 | cytochrome P450 family 51 subfamily A member 1 | 2 | 2 | ||||||||
MIRT462917 | ZNRF3 | zinc and ring finger 3 | 2 | 2 | ||||||||
MIRT463022 | ZNF70 | zinc finger protein 70 | 2 | 2 | ||||||||
MIRT463074 | ZNF639 | zinc finger protein 639 | 2 | 2 | ||||||||
MIRT463130 | ZNF451 | zinc finger protein 451 | 2 | 4 | ||||||||
MIRT463627 | YY1 | YY1 transcription factor | 2 | 2 | ||||||||
MIRT467015 | SSBP2 | single stranded DNA binding protein 2 | 2 | 2 | ||||||||
MIRT467127 | SRGAP1 | SLIT-ROBO Rho GTPase activating protein 1 | 2 | 8 | ||||||||
MIRT468526 | SERTAD2 | SERTA domain containing 2 | 2 | 4 | ||||||||
MIRT468584 | SERBP1 | SERPINE1 mRNA binding protein 1 | 2 | 6 | ||||||||
MIRT469540 | RBBP8 | RB binding protein 8, endonuclease | 2 | 2 | ||||||||
MIRT469876 | PURB | purine rich element binding protein B | 2 | 4 | ||||||||
MIRT471577 | PARD6B | par-6 family cell polarity regulator beta | 2 | 2 | ||||||||
MIRT472110 | NME2 | NME/NM23 nucleoside diphosphate kinase 2 | 2 | 2 | ||||||||
MIRT472127 | NME1-NME2 | NME1-NME2 readthrough | 2 | 2 | ||||||||
MIRT472423 | NCKAP1 | NCK associated protein 1 | 2 | 2 | ||||||||
MIRT472829 | MTMR10 | myotubularin related protein 10 | 2 | 4 | ||||||||
MIRT473022 | MRPS14 | mitochondrial ribosomal protein S14 | 2 | 2 | ||||||||
MIRT473408 | MDM4 | MDM4, p53 regulator | 2 | 2 | ||||||||
MIRT474122 | LIPC | lipase C, hepatic type | 2 | 2 | ||||||||
MIRT474927 | KCTD20 | potassium channel tetramerization domain containing 20 | 2 | 2 | ||||||||
MIRT476807 | FNDC3B | fibronectin type III domain containing 3B | 2 | 2 | ||||||||
MIRT478006 | DNAL1 | dynein axonemal light chain 1 | 2 | 2 | ||||||||
MIRT479200 | CLCN5 | chloride voltage-gated channel 5 | 2 | 6 | ||||||||
MIRT479671 | CCSER2 | coiled-coil serine rich protein 2 | 2 | 2 | ||||||||
MIRT479917 | CCDC117 | coiled-coil domain containing 117 | 2 | 6 | ||||||||
MIRT479977 | CARD10 | caspase recruitment domain family member 10 | 2 | 2 | ||||||||
MIRT480731 | BPTF | bromodomain PHD finger transcription factor | 2 | 6 | ||||||||
MIRT481100 | B3GALNT2 | beta-1,3-N-acetylgalactosaminyltransferase 2 | 2 | 2 | ||||||||
MIRT481160 | AVL9 | AVL9 cell migration associated | 2 | 6 | ||||||||
MIRT481393 | ATG12 | autophagy related 12 | 2 | 2 | ||||||||
MIRT481433 | ASB6 | ankyrin repeat and SOCS box containing 6 | 2 | 2 | ||||||||
MIRT482083 | ALG9 | ALG9, alpha-1,2-mannosyltransferase | 2 | 2 | ||||||||
MIRT484667 | HOXD3 | homeobox D3 | 2 | 4 | ||||||||
MIRT485940 | ECSIT | ECSIT signalling integrator | 2 | 4 | ||||||||
MIRT485950 | BRSK1 | BR serine/threonine kinase 1 | 2 | 2 | ||||||||
MIRT487600 | NKD2 | naked cuticle homolog 2 | 2 | 4 | ||||||||
MIRT487666 | HPCAL1 | hippocalcin like 1 | 2 | 4 | ||||||||
MIRT489966 | GNB2 | G protein subunit beta 2 | 2 | 2 | ||||||||
MIRT490332 | ANK1 | ankyrin 1 | 2 | 4 | ||||||||
MIRT491314 | LRFN1 | leucine rich repeat and fibronectin type III domain containing 1 | 2 | 2 | ||||||||
MIRT493193 | MINK1 | misshapen like kinase 1 | 2 | 4 | ||||||||
MIRT493300 | LLGL2 | LLGL2, scribble cell polarity complex component | 2 | 2 | ||||||||
MIRT493816 | FSCN1 | fascin actin-bundling protein 1 | 2 | 2 | ||||||||
MIRT496977 | RPS6KA2 | ribosomal protein S6 kinase A2 | 2 | 2 | ||||||||
MIRT512229 | ATXN3 | ataxin 3 | 2 | 6 | ||||||||
MIRT515141 | ZNF799 | zinc finger protein 799 | 2 | 4 | ||||||||
MIRT516647 | SMC5 | structural maintenance of chromosomes 5 | 2 | 2 | ||||||||
MIRT517952 | TRIM59 | tripartite motif containing 59 | 2 | 2 | ||||||||
MIRT520971 | SPPL2A | signal peptide peptidase like 2A | 2 | 4 | ||||||||
MIRT521569 | PTPLB | 3-hydroxyacyl-CoA dehydratase 2 | 1 | 1 | ||||||||
MIRT522918 | KCNE3 | potassium voltage-gated channel subfamily E regulatory subunit 3 | 2 | 2 | ||||||||
MIRT532713 | SNRPD3 | small nuclear ribonucleoprotein D3 polypeptide | 2 | 2 | ||||||||
MIRT540809 | SLC35F5 | solute carrier family 35 member F5 | 2 | 2 | ||||||||
MIRT550734 | PMPCA | peptidase, mitochondrial processing alpha subunit | 2 | 4 | ||||||||
MIRT551293 | MCF2L2 | MCF.2 cell line derived transforming sequence-like 2 | 2 | 4 | ||||||||
MIRT559740 | ACOX1 | acyl-CoA oxidase 1 | 2 | 2 | ||||||||
MIRT564410 | EMILIN2 | elastin microfibril interfacer 2 | 2 | 2 | ||||||||
MIRT565240 | TRAF6 | TNF receptor associated factor 6 | 2 | 2 | ||||||||
MIRT568911 | ATP6V1B1 | ATPase H+ transporting V1 subunit B1 | 2 | 2 | ||||||||
MIRT575232 | Fut1 | fucosyltransferase 1 | 2 | 2 | ||||||||
MIRT576224 | Srsf1 | serine/arginine-rich splicing factor 1 | 2 | 2 | ||||||||
MIRT607724 | LIMS1 | LIM zinc finger domain containing 1 | 2 | 2 | ||||||||
MIRT608090 | CRISPLD2 | cysteine rich secretory protein LCCL domain containing 2 | 2 | 2 | ||||||||
MIRT613920 | POU3F1 | POU class 3 homeobox 1 | 2 | 2 | ||||||||
MIRT618520 | SELPLG | selectin P ligand | 2 | 2 | ||||||||
MIRT624703 | AQR | aquarius intron-binding spliceosomal factor | 2 | 2 | ||||||||
MIRT624770 | AKR1D1 | aldo-keto reductase family 1 member D1 | 2 | 2 | ||||||||
MIRT625720 | SPI1 | Spi-1 proto-oncogene | 2 | 2 | ||||||||
MIRT629975 | MRPL36 | mitochondrial ribosomal protein L36 | 2 | 2 | ||||||||
MIRT631356 | ZFP82 | ZFP82 zinc finger protein | 2 | 2 | ||||||||
MIRT631426 | CDNF | cerebral dopamine neurotrophic factor | 2 | 2 | ||||||||
MIRT631665 | NDUFV3 | NADH:ubiquinone oxidoreductase subunit V3 | 2 | 2 | ||||||||
MIRT631735 | SF3B1 | splicing factor 3b subunit 1 | 2 | 2 | ||||||||
MIRT632334 | TCEANC2 | transcription elongation factor A N-terminal and central domain containing 2 | 2 | 2 | ||||||||
MIRT632419 | SLC30A5 | solute carrier family 30 member 5 | 2 | 2 | ||||||||
MIRT632531 | PSMB2 | proteasome subunit beta 2 | 2 | 2 | ||||||||
MIRT633264 | LDLR | low density lipoprotein receptor | 2 | 2 | ||||||||
MIRT634327 | SLC43A2 | solute carrier family 43 member 2 | 2 | 2 | ||||||||
MIRT634753 | CRCP | CGRP receptor component | 2 | 2 | ||||||||
MIRT635412 | KIAA1614 | KIAA1614 | 2 | 2 | ||||||||
MIRT636281 | RFFL | ring finger and FYVE like domain containing E3 ubiquitin protein ligase | 2 | 2 | ||||||||
MIRT636291 | RAD51L3-RFFL | RAD51L3-RFFL readthrough | 2 | 2 | ||||||||
MIRT640265 | FANCA | Fanconi anemia complementation group A | 2 | 2 | ||||||||
MIRT641738 | TXNL1 | thioredoxin like 1 | 2 | 2 | ||||||||
MIRT643276 | ZNF566 | zinc finger protein 566 | 2 | 2 | ||||||||
MIRT643528 | ERAP2 | endoplasmic reticulum aminopeptidase 2 | 2 | 2 | ||||||||
MIRT643555 | C11orf70 | chromosome 11 open reading frame 70 | 2 | 2 | ||||||||
MIRT647027 | NQO2 | N-ribosyldihydronicotinamide:quinone reductase 2 | 2 | 2 | ||||||||
MIRT647298 | RBM43 | RNA binding motif protein 43 | 2 | 2 | ||||||||
MIRT648124 | SEMA3E | semaphorin 3E | 2 | 4 | ||||||||
MIRT648611 | TPCN2 | two pore segment channel 2 | 2 | 2 | ||||||||
MIRT648717 | IL10RB | interleukin 10 receptor subunit beta | 2 | 2 | ||||||||
MIRT649425 | CDC14B | cell division cycle 14B | 2 | 2 | ||||||||
MIRT650029 | DSG3 | desmoglein 3 | 2 | 2 | ||||||||
MIRT650281 | TAS2R5 | taste 2 receptor member 5 | 2 | 2 | ||||||||
MIRT650529 | CCDC77 | coiled-coil domain containing 77 | 2 | 2 | ||||||||
MIRT654240 | RNF115 | ring finger protein 115 | 2 | 2 | ||||||||
MIRT657032 | KCNJ6 | potassium voltage-gated channel subfamily J member 6 | 2 | 2 | ||||||||
MIRT658408 | FAM212B | family with sequence similarity 212 member B | 2 | 2 | ||||||||
MIRT659442 | CNNM4 | cyclin and CBS domain divalent metal cation transport mediator 4 | 2 | 2 | ||||||||
MIRT661080 | FFAR2 | free fatty acid receptor 2 | 2 | 2 | ||||||||
MIRT661529 | NWD1 | NACHT and WD repeat domain containing 1 | 2 | 2 | ||||||||
MIRT661876 | PDLIM5 | PDZ and LIM domain 5 | 2 | 2 | ||||||||
MIRT662100 | ZNF419 | zinc finger protein 419 | 2 | 2 | ||||||||
MIRT662136 | ZC3H8 | zinc finger CCCH-type containing 8 | 2 | 2 | ||||||||
MIRT663638 | HM13 | histocompatibility minor 13 | 2 | 2 | ||||||||
MIRT663703 | ABHD17B | abhydrolase domain containing 17B | 2 | 2 | ||||||||
MIRT663847 | TRIM72 | tripartite motif containing 72 | 2 | 2 | ||||||||
MIRT664769 | MESDC2 | mesoderm development LRP chaperone | 2 | 2 | ||||||||
MIRT665481 | VSTM4 | V-set and transmembrane domain containing 4 | 2 | 2 | ||||||||
MIRT666533 | RNF157 | ring finger protein 157 | 2 | 2 | ||||||||
MIRT668107 | GK5 | glycerol kinase 5 (putative) | 2 | 2 | ||||||||
MIRT668984 | CKAP4 | cytoskeleton associated protein 4 | 2 | 4 | ||||||||
MIRT669742 | HSPE1-MOB4 | HSPE1-MOB4 readthrough | 2 | 2 | ||||||||
MIRT671010 | MOB4 | MOB family member 4, phocein | 2 | 2 | ||||||||
MIRT671583 | SPIRE2 | spire type actin nucleation factor 2 | 2 | 2 | ||||||||
MIRT673261 | INO80 | INO80 complex subunit | 2 | 2 | ||||||||
MIRT673533 | ADRBK2 | G protein-coupled receptor kinase 3 | 2 | 2 | ||||||||
MIRT674714 | FAM73A | mitoguardin 1 | 2 | 2 | ||||||||
MIRT675205 | ZNF554 | zinc finger protein 554 | 2 | 2 | ||||||||
MIRT676488 | DSN1 | DSN1 homolog, MIS12 kinetochore complex component | 2 | 2 | ||||||||
MIRT676705 | GXYLT2 | glucoside xylosyltransferase 2 | 2 | 2 | ||||||||
MIRT676851 | ZMYM1 | zinc finger MYM-type containing 1 | 2 | 2 | ||||||||
MIRT676855 | RAB3B | RAB3B, member RAS oncogene family | 2 | 2 | ||||||||
MIRT676915 | PHLDA3 | pleckstrin homology like domain family A member 3 | 2 | 2 | ||||||||
MIRT677000 | CYP20A1 | cytochrome P450 family 20 subfamily A member 1 | 2 | 2 | ||||||||
MIRT677188 | PDE12 | phosphodiesterase 12 | 2 | 2 | ||||||||
MIRT677473 | SLC7A11 | solute carrier family 7 member 11 | 2 | 2 | ||||||||
MIRT677562 | C19orf52 | translocase of inner mitochondrial membrane 29 | 2 | 2 | ||||||||
MIRT677779 | FKTN | fukutin | 2 | 2 | ||||||||
MIRT677896 | DCP1A | decapping mRNA 1A | 2 | 2 | ||||||||
MIRT677996 | GATC | glutamyl-tRNA amidotransferase subunit C | 2 | 2 | ||||||||
MIRT678239 | HMGB1 | high mobility group box 1 | 2 | 4 | ||||||||
MIRT678313 | MCM8 | minichromosome maintenance 8 homologous recombination repair factor | 2 | 2 | ||||||||
MIRT678437 | PDE4C | phosphodiesterase 4C | 2 | 2 | ||||||||
MIRT678480 | RNF222 | ring finger protein 222 | 2 | 2 | ||||||||
MIRT678591 | ZNF91 | zinc finger protein 91 | 2 | 2 | ||||||||
MIRT678863 | SLC7A14 | solute carrier family 7 member 14 | 2 | 2 | ||||||||
MIRT679241 | LRP10 | LDL receptor related protein 10 | 2 | 2 | ||||||||
MIRT679388 | WDR92 | WD repeat domain 92 | 2 | 2 | ||||||||
MIRT679501 | ZNF106 | zinc finger protein 106 | 2 | 2 | ||||||||
MIRT679581 | UGGT1 | UDP-glucose glycoprotein glucosyltransferase 1 | 2 | 2 | ||||||||
MIRT679827 | TMEM106B | transmembrane protein 106B | 2 | 2 | ||||||||
MIRT679842 | GPR75 | G protein-coupled receptor 75 | 2 | 2 | ||||||||
MIRT679860 | ZFP30 | ZFP30 zinc finger protein | 2 | 2 | ||||||||
MIRT680733 | PRICKLE1 | prickle planar cell polarity protein 1 | 2 | 2 | ||||||||
MIRT680922 | STX2 | syntaxin 2 | 2 | 2 | ||||||||
MIRT680953 | CEP104 | centrosomal protein 104 | 2 | 2 | ||||||||
MIRT681053 | ZDBF2 | zinc finger DBF-type containing 2 | 2 | 2 | ||||||||
MIRT681967 | TFCP2 | transcription factor CP2 | 2 | 2 | ||||||||
MIRT682010 | ATP5S | ATP synthase, H+ transporting, mitochondrial Fo complex subunit s (factor B) | 2 | 2 | ||||||||
MIRT682061 | B4GALT7 | beta-1,4-galactosyltransferase 7 | 2 | 4 | ||||||||
MIRT682070 | QPCTL | glutaminyl-peptide cyclotransferase like | 2 | 2 | ||||||||
MIRT683356 | SCARF1 | scavenger receptor class F member 1 | 2 | 2 | ||||||||
MIRT683699 | LAX1 | lymphocyte transmembrane adaptor 1 | 2 | 2 | ||||||||
MIRT684268 | PRPF4 | pre-mRNA processing factor 4 | 2 | 2 | ||||||||
MIRT685500 | MED16 | mediator complex subunit 16 | 2 | 2 | ||||||||
MIRT686876 | SLC25A32 | solute carrier family 25 member 32 | 2 | 2 | ||||||||
MIRT690869 | PLEKHG2 | pleckstrin homology and RhoGEF domain containing G2 | 2 | 2 | ||||||||
MIRT691139 | HJURP | Holliday junction recognition protein | 2 | 2 | ||||||||
MIRT691195 | NIF3L1 | NGG1 interacting factor 3 like 1 | 2 | 2 | ||||||||
MIRT691780 | SLC24A4 | solute carrier family 24 member 4 | 2 | 2 | ||||||||
MIRT692901 | MPL | MPL proto-oncogene, thrombopoietin receptor | 2 | 2 | ||||||||
MIRT694551 | BPNT1 | 3'(2'), 5'-bisphosphate nucleotidase 1 | 2 | 2 | ||||||||
MIRT695421 | ADH5 | alcohol dehydrogenase 5 (class III), chi polypeptide | 2 | 2 | ||||||||
MIRT695956 | FANCM | Fanconi anemia complementation group M | 2 | 2 | ||||||||
MIRT696615 | CRIPT | CXXC repeat containing interactor of PDZ3 domain | 2 | 2 | ||||||||
MIRT700682 | PPAP2B | phospholipid phosphatase 3 | 2 | 2 | ||||||||
MIRT701215 | ORAI2 | ORAI calcium release-activated calcium modulator 2 | 2 | 2 | ||||||||
MIRT702196 | LRRC58 | leucine rich repeat containing 58 | 2 | 2 | ||||||||
MIRT702837 | HOOK3 | hook microtubule tethering protein 3 | 2 | 2 | ||||||||
MIRT703652 | FAM60A | SIN3-HDAC complex associated factor | 2 | 2 | ||||||||
MIRT705679 | ANKRD40 | ankyrin repeat domain 40 | 2 | 2 | ||||||||
MIRT706650 | SMIM19 | small integral membrane protein 19 | 2 | 2 | ||||||||
MIRT711087 | NEUROD2 | neuronal differentiation 2 | 2 | 2 | ||||||||
MIRT724961 | PTK6 | protein tyrosine kinase 6 | 2 | 2 | ||||||||
MIRT735597 | BCL6 | B-cell CLL/lymphoma 6 | 1 | 0 |
miRNA-Drug Resistance Associations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|